national economic research associates 1255 23rd street nw washington dc 20037 telephone 202 466 3510 facsimile 3605 internet http www nera com issues raised in the fda s proposed rule on removing essential use designation for albuterol mdis by richard p rozek and emily r bishko comments submitted to us food drug administration docket no 2003 0029 august 13 2004 n e a consulting economists table of contents i introduction 1 ii previous submission 4 summary results b identical co payments brand generic products 7 iii critique analysis presented notice 8 comparison our 9 estimates cost impact patients 2 reduced demand 11 3 year fluctuation sales 12 iv effective competition choices currently available physicians development asthma copd 14 c two sellers likely create sufficient 15 pharmaceutical examples cfc other literature
